{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:44:26Z","timestamp":1776692666828,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cjca.2023.04.021","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T20:14:27Z","timestamp":1682799267000},"page":"1369-1379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of Adverse Outcome in High-Risk Percutaneous Coronary Interventions Patients"],"prefix":"10.1016","volume":"39","author":[{"given":"Ido","family":"Peles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orit","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Tsaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aref","family":"El-Nasasra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yigal","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hezzy","family":"Shmueli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miri","family":"Merkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Zahger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7907-6002","authenticated-orcid":false,"given":"Edward","family":"Koifman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.04.021_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcin.2008.11.005","article-title":"A\u00a0prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial). Initial U.S. experience","volume":"2","author":"Dixon","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A\u00a0prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.04.021_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2019.05.065","article-title":"Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI","volume":"2933","author":"Chieffo","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2023.04.021_bib4","article-title":"Feasibility and safety of high-risk percutaneous coronary intervention without mechanical circulatory support","volume":"14","author":"Khalid","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2019.03.050","article-title":"Impact of hemodynamic support on outcome in patients undergoing high-risk percutaneous coronary intervention","volume":"124","author":"Shamekhi","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.04.021_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","article-title":"The evolving landscape of impella use in the united states among patients undergoing percutaneous coronary intervention with mechanical circulatory support","volume":"141","author":"Amin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.04.021_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.04.021_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","article-title":"Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and noninfarction related cardiogenic shock in the United States","volume":"107","author":"Shah","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"10 suppl 1","key":"10.1016\/j.cjca.2023.04.021_bib9","first-page":"S30","article-title":"The ongoing saga of the evolution of percutaneous coronary intervention: from balloon angioplasty to recent innovations to future prospects","volume":"38","author":"Picard","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.04.021_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2010.1190","article-title":"Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial","volume":"304","author":"Perera","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.04.021_bib11","first-page":"728","article-title":"Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience","volume":"80","author":"Alli","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib12","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2009.09.018","article-title":"Supported high-risk percutaneous coronary intervention with the Impella 2.5 device. The Europella registry","volume":"54","author":"Sjauw","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.04.021_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MAT.0000000000000894","article-title":"Left ventricular assist devices: how do we define success?","volume":"65","author":"Anwer","year":"2019","journal-title":"ASAIO J"},{"key":"10.1016\/j.cjca.2023.04.021_bib14","first-page":"260","article-title":"Percutaneous left ventricular assist device vs intra-aortic balloon pump in patients with severe left ventricular dysfunction undergoing cardiovascular intervention: a meta-analysis","volume":"4","author":"Hu","year":"2018","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.cjca.2023.04.021_bib15","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.04.021_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13584-017-0135-6","article-title":"Medical care epidemiology and unwarranted variation: the Israeli case","volume":"6","author":"Goodman","year":"2017","journal-title":"Isr J Health Policy Res"},{"key":"10.1016\/j.cjca.2023.04.021_bib17","first-page":"1","article-title":"Israel: health system review","volume":"17","author":"Rosen","year":"2015","journal-title":"Health Syst Transit"},{"key":"10.1016\/j.cjca.2023.04.021_bib18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.04.021_bib19","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.04.021_bib20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jcin.2013.03.020","article-title":"Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)","volume":"6","author":"Brennan","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcin.2021.09.039","article-title":"Defining percutaneous coronary intervention complexity and risk: an analysis of the United Kingdom BCIS database 2006-2016","volume":"15","author":"Protty","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib22","first-page":"532","article-title":"Effects of left ventricular unloading by Impella Recover LP2.5 on coronary hemodynamics","volume":"70","author":"Remmelink","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib23","first-page":"e26","article-title":"Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry","volume":"97","author":"Azzalini","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2017.09.007","article-title":"The cVAD registry for percutaneous temporary hemodynamic support: a prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure","volume":"199","author":"Vetrovec","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2023.04.021_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.112.132209","article-title":"Long-term mortality data from the Balloon Pump\u2013Assisted Coronary Intervention Study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention","volume":"127","author":"Perera","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.04.021_bib26","first-page":"717","article-title":"Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella registry","volume":"80","author":"Maini","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.04.021_bib27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2005.10.037","article-title":"Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5","volume":"97","author":"Henriques","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.04.021_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.carrev.2012.01.003","article-title":"Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what?","volume":"13","author":"Shah","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cjca.2023.04.021_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock","volume":"323","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"issue":"10 suppl 1","key":"10.1016\/j.cjca.2023.04.021_bib30","first-page":"S1","article-title":"Forty years of innovations: the past, present, and future of interventional cardiology","volume":"38","year":"2022","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23003690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23003690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:52:08Z","timestamp":1760107928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23003690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0828282X23003690"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.04.021","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Adverse Outcome in High-Risk Percutaneous Coronary Interventions Patients","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}